Zealand Pharma

Phone: +45 88 77 36 00

E-mail: info@zealandpharma.com

Web:https://www.zealandpharma.com/

Founded 1998
Headquarters Sydmarken 11, 2860 Søborg, Denmark
Key people
  • Emmanuel Dulac (CEO)
  • Martin Nicklasson (Chairman)
Products
  • Lyxumia
  • Danegaoptide
Total assets 694,626,000 Danish krone (2016)
Total equity 1,4 billion Danish kroner (2019)
Number of employees About 200
Website https://www.zealandpharma.com/

Zealand Pharma A/S was founded in 1998 and is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. We intend to be a leader in specialty medicines focusing on metabolic and gastrointestinal diseases and other rare disease areas with significant unmet medical needs. Zealand employs more than 300 people in Denmark and the US and has a portfolio of medicines  and product candidates, including license collaborations with Boehringer Ingelheim.

For detailed contact information visit location pages below.

Zealand Pharma's locations around the world

EuropeExpand
North AmericaExpand

Clinical Trials sponsored by Zealand Pharma

3
購読する